NHE3 (Slc9a3) (rat) Antibody - FFPE Validated

About the Target

This antibody helps you investigate NHE3 (Slc9a3) while keeping condition-to-condition contrasts straightforward. NHE3 is a trafficking-sensitive transporter that can shift between intracellular pools and the plasma membrane. Use matched handling so differences reflect biology rather than processing.

Monitoring NHE3 alongside context markers can improve interpretation when phenotypes are subtle.

Research Context

Modulators that affect trafficking, phosphorylation, or ligand binding can change apparent distribution and signal intensity. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows. Kidney-focused model systems may monitor this target when evaluating transport, barrier features, or compartment identity.

Consider these angles when interpreting target-level changes:

• relative abundance across engineered constructs
• patterns consistent with apical or basolateral sorting
• surface versus intracellular pool distribution
• stimulus-dependent trafficking and turnover

Variant Considerations

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. This matters because epitope exposure and background can vary with preparation and extraction steps. Standardize key parameters so differences reflect biology rather than handling.

When interpreting NHE3, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

If your study spans multiple model systems, it can help to define a shared reference condition for NHE3 so cross-sample contrasts stay meaningful.

With consistent handling, the fixed-section format can make NHE3 (Slc9a3) comparisons easier to reproduce across runs.